Broderick Brian C lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 99,637 shares of the company's stock after selling 2,427 shares during the period. Procter & Gamble comprises 3.1% of Broderick Brian C's portfolio, making the stock its 11th largest position. Broderick Brian C's holdings in Procter & Gamble were worth $15,874,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the company. Stableford Capital II LLC raised its stake in shares of Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after buying an additional 61 shares during the last quarter. Bernard Wealth Management Corp. grew its holdings in Procter & Gamble by 20.2% during the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after acquiring an additional 63 shares during the period. B & T Capital Management DBA Alpha Capital Management lifted its stake in shares of Procter & Gamble by 2.3% in the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock valued at $476,000 after purchasing an additional 63 shares during the period. Private Management Group Inc. lifted its stake in shares of Procter & Gamble by 4.8% in the 1st quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock valued at $236,000 after purchasing an additional 64 shares during the period. Finally, Lantz Financial LLC boosted its position in shares of Procter & Gamble by 1.2% in the 2nd quarter. Lantz Financial LLC now owns 5,237 shares of the company's stock worth $834,000 after purchasing an additional 64 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the company. Barclays cut their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 1st. BNP Paribas Exane lowered their price target on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Berenberg Bank lifted their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research note on Wednesday, September 17th. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Finally, Evercore ISI reissued an "in-line" rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $173.11.
Read Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of the company's stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the transaction, the insider owned 12,616 shares of the company's stock, valued at $1,920,533.68. This represents a 3.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG stock opened at $152.60 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company's 50 day moving average price is $155.30 and its two-hundred day moving average price is $159.79. The company has a market capitalization of $357.16 billion, a P/E ratio of 23.44, a price-to-earnings-growth ratio of 4.13 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.